Average Co-Inventor Count = 3.26
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Smithkline Beecham Corporation (20 from 2,198 patents)
2. Glaxosmithkline LLC (1 from 356 patents)
3. Aventis Pharmaceuticals Inc. (1 from 207 patents)
4. Glaxosmithkline Intellectual Property (no.2) Limited (1 from 92 patents)
23 patents:
1. 8901119 - Peptide deformylase inhibitors
2. 7919528 - Peptide deformylase inhibitors
3. 7612075 - Substituted oxoazaheterocyclyl compounds
4. 7332485 - Peptide deformylase inhibitors
5. 6852882 - Peptide deformylase inhibitors
6. 6037367 - Substituted-pent-4-ynoic acids
7. 5990119 - 1,4,4-(trisubstituted)cyclohexane monomers and related compounds
8. 5977122 - 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
9. 5900417 - 1,3,3-(Trisubstituted)cyclohexanemonomers and related compounds
10. 5892098 - 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
11. 5891883 - 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
12. 5869677 - 3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related
13. 5866616 - 3,3-(disubstituted) cyclohexan-1-ol monomers and related compounds
14. 5863926 - 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related
15. 5861421 - 4,4-(disubstituted) cyclohexan-1-one monomers and related compounds